BCR::ABL1 oncogene is also present in 20–30% of acute lymphoblastic leukemia (Ph + ALL) cases, a rare aggressive lymphoid malignancy that predominantly involves B-lymphocytes [5–9]. Here, ABL1 is linked to acute lymphoblastic leukemia.